HK2 Cancer Research Results

HK2, Hexokinase 2: Click to Expand ⟱
Source:
Type: enzyme
HK2 (Hexokinase 2) is an enzyme that plays a crucial role in glycolysis, the process by which cells convert glucose into energy. HK2 is a key regulatory enzyme in the glycolytic pathway, and it is primarily expressed in various tissues, including muscle, brain, and cancer cells.
HK2 has been shown to be overexpressed in many types of tumors, including breast, lung, and colon cancer. This overexpression may contribute to the development and progression of cancer by promoting glycolysis and energy production in cancer cells.
HK2 is a key regulatory enzyme in the glycolytic pathway.
HK2 plays a role in the regulation of glucose metabolism in diabetes.
HK2 is involved in the regulation of cell proliferation, apoptosis, and autophagy.

HK2 Inhibitors:
-2DG
-Curcumin
-Resveratrol
-EGCG
-Berberine
-Methyl Jasmonate (MJ)
-Honokiol


Scientific Papers found: Click to Expand⟱
2448- SFN,    Sulforaphane and bladder cancer: a potential novel antitumor compound
- Review, Bladder, NA
Apoptosis↑, TumCG↓, TumCI↓, TumMeta↓, glucoNG↓, ChemoSen↑, TumCCA↑, Casp3↑, Casp7↑, cl‑PARP↑, survivin↓, EGFR↓, HER2/EBBR2↓, ATP↓, Glycolysis↓, mt-OXPHOS↓, AKT1↓, HK2↓, Hif1a↓, ROS↑, NRF2↑, EMT↓, COX2/PTGS2↓, MMP2↓, MMP9↓, Zeb1↓, Snail↓, HDAC↓, HATs↓, MMP↓, Cyt‑c↓, Shh↓, Smo↓, Gli1↓, BioAv↝, BioAv↝, Dose↝,
2410- SIL,    Autophagy activated by silibinin contributes to glioma cell death via induction of oxidative stress-mediated BNIP3-dependent nuclear translocation of AIF
- in-vitro, GBM, U87MG - in-vitro, GBM, U251 - in-vivo, NA, NA
TumAuto↑, ATP↓, Glycolysis↓, H2O2↑, P53↑, GSH↓, xCT/SLC7A11↓, BNIP3↝, MMP↑, mt-ROS↑, mtDam↑, HK2↓, PFKP↓, PKM2↓, TumCG↓,
1140- SIL,    Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
- in-vitro, PC, AsPC-1 - in-vivo, PC, NA - in-vitro, PC, MIA PaCa-2 - in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
TumCG↓, Glycolysis↓, cMyc↓, STAT3↓, TumCP↓, Weight∅, Strength↑, DNAdam↑, Casp3↑, Casp9↑, GLUT1↓, HK2↓, LDHA↓, GlucoseCon↓, lactateProd↓, PPP↓, Ki-67↓, p‑STAT3↓, cachexia↓,
2419- SK,    Regulation of glycolysis and the Warburg effect in wound healing
- in-vivo, Nor, NA
Glycolysis↓, GLUT1↓, GLUT3↓, HK2↓, HK1↓, PFK1↓, PFK2↓, PKM2↓, lactateProd↓, GlucoseCon↓,
2416- SK,    Shikonin induces cell death by inhibiting glycolysis in human testicular cancer I-10 and seminoma TCAM-2 cells
- in-vitro, Testi, TCAM-2
MMP↓, ROS↑, lactateProd↓, Bcl-2↓, cl‑Casp3↓, PKM2↓, GLUT1↓, HK2↓, LC3B↑,
2415- SK,    Shikonin induces programmed death of fibroblast synovial cells in rheumatoid arthritis by inhibiting energy pathways
- in-vivo, Arthritis, NA
Apoptosis?, TumAuto↑, ROS↑, ATP↓, Glycolysis↓, PI3K↓, Akt↓, mTOR↓, *Apoptosis↓, *Inflam↓, *TNF-α↓, *IL6↓, *IL8↓, *IL10↓, *IL17↓, *hepatoP↑, *RenoP↑, PKM2↓, GLUT1↓, HK2↓,
2362- SK,    RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
- in-vitro, GBM, U87MG - in-vivo, GBM, NA - in-vitro, GBM, U251
RIP1↑, RIP3↑, Glycolysis↓, G6PD↓, HK2↓, PKM2↓, H2O2↑, GSH↓, ROS↑,
2192- SK,    Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation
- in-vitro, ESCC, KYSE-510 - in-vitro, ESCC, Eca109 - in-vivo, NA, NA
TumCP↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, p‑PKM2↓, p‑STAT3↓, GLUT1↓, HK2↓, TumW↓,
9291- TERPs,    Plant-derived terpenoids modulating cancer cell metabolism and cross-linked signaling pathways: an updated reviews
- Review, Var, NA
AntiCan?, *Inflam↓, *AntiBio↑, *AntiViral↑, Ingr↝, HK2↓, ACC1↓, PKM2↓, ENO1↓, GLUT1↓, PI3K↓, Akt↓, mTOR↓, FASN↓, Apoptosis↑, Bcl-2↓, NRF2↓,
3431- TQ,    PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
- in-vitro, CRC, HCT116 - in-vitro, CRC, SW48
Glycolysis↓, Warburg↓, HK2↓, ATP↓, NADPH↓, PI3K↓, Akt↓, TumCP↓, E-cadherin↑, N-cadherin↓, Hif1a↓, PKM2↓, GlucoseCon↓, lactateProd↓, EMT↓,
2454- Trip,    Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ
- in-vitro, HNSCC, HaCaT - in-vivo, NA, NA
GSDME-N↑, Pyro↑, cMyc↓, HK2↓, BAD↑, BAX↑, Casp3↑, NRF2↓, xCT/SLC7A11↓, ROS↑, Synergy↑, Glycolysis↓, GlucoseCon↓, lactateProd↓, ATP↓, xCT/SLC7A11↓, eff↑,
2411- UA,    Ursolic acid in health and disease
- Review, Var, NA
Inflam↓, antiOx↑, NF-kB↓, Bcl-xL↓, Bcl-2↓, cycD1/CCND1↓, Ki-67↓, CD31/PECAM-1↓, STAT3↓, EGFR↓, P53↑, P21↓, HK2↓, PKM2↓, ATP↓, lactateProd↓, p‑ERK↓, MMP↓, NO↑, ATM↑, Casp3↑, AMPK↑, JNK↑, FAO↑, FASN↓, *GSH↑, *SOD↑, *Catalase↑, *GPx↑, *GSTs↑, neuroP↑,
2350- UA,    Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
Akt↓, Glycolysis↓, HK2↓, PKM2↓, ATP↓, lactateProd↓, AMPK↑, TumAuto↑, Apoptosis↑, ERK↓, MMP↓, NO↑, ROS↑, DNAdam↑,
5021- UA,    Anticancer effect of ursolic acid via mitochondria-dependent pathways
- Review, Var, NA
Inflam↓, TNF-α↓, IL6↓, IL17↓, NF-kB↓, COX2/PTGS2↓, *AntiDiabetic↑, *hepatoP↑, ALAT↓, AST↓, TumCP↓, Apoptosis↑, TumCCA↑, TumAuto↑, tumCV↓, TumCMig↓, Glycolysis↓, ATP↓, lactateProd↓, HK2↓, PKA↓, COX2/PTGS2↓, mtDam↑, Casp3↑, Casp8↑, Casp9↑, Akt↓, ROS↑, MMP↓, P53↑,
3141- VitC,    High-dose Vitamin C inhibits PD-L1 expression by activating AMPK in colorectal cancer
- in-vitro, CRC, HCT116
Glycolysis↓, Synergy↑, PD-L1↓, AMPK↑, HK2↓, NF-kB↓, Warburg↓, tumCV↓, GLUT1↓, PKM2↓, LDHA↓, CD4+↑, CD8+↑,
3142- VitC,    Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vitro, Nor, MCF12A
TET2↑, Apoptosis↑, TRAIL↑, BAX↑, Casp↑, Cyt‑c↑, HK2↓, PDK1 / PDPK1↓, BNIP3↓,
2365- VitD3,    Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway
- in-vitro, Lung, A549 - in-vitro, Lung, H1975 - in-vivo, NA, NA
Glycolysis↓, Warburg↓, GLUT1↓, LDHA↓, HK2↓, PKM2↓, OCT4↓, SOX2↓, Nanog↓, PI3K↓, Akt↓, mTOR↓,
2369- VitD3,    Long Non-coding RNA MEG3 Activated by Vitamin D Suppresses Glycolysis in Colorectal Cancer via Promoting c-Myc Degradation
- in-vitro, CRC, DLD1 - in-vitro, CRC, RKO
MEG3↑, Glycolysis↓, lactateProd↓, LDHA↓, PKM2↓, HK2↓,
1214- VitK2,    Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells
- in-vitro, Bladder, T24/HTB-9 - in-vitro, Bladder, J82
Glycolysis↑, GlucoseCon↑, lactateProd↑, TCA↓, PI3K↑, Akt↑, AMPK↑, mTORC1↓, TumAuto↑, GLUT1↑, HK2↑, LDHA↑, ACC↓, PDH↓, eff↓, cMyc↓, Hif1a↑, p‑Akt↑, eff↓, eff↓, eff↓, eff↓, ROS↑,
2301- Wog,    Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
- Review, Var, NA
HK2↓, PDK1 / PDPK1↓, LDHA↓, Hif1a↓, PI3K↓, Akt↓, Glycolysis↓, P53↑, GLUT1↓,
2397- Wor,    Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
- Review, Var, NA
lactateProd↓, GlucoseCon↓, GLUT3↓, HK2↓, PKM2↓, LDHA↓,
2425- γ-Toc,    Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis
- in-vitro, Var, MCF7 - in-vivo, Var, NA
TumCG↓, GlucoseCon↓, ATP↓, lactateProd↓, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDHA↓, Akt↓, p‑mTOR↓, cMyc↓,

Showing Research Papers: 151 to 172 of 172
Prev Page 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 172

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 2,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 2,   GSH↓, 13,   GSTs↑, 1,   H2O2↑, 5,   HO-1↓, 1,   HO-1↑, 4,   Iron↑, 2,   lipid-P↓, 1,   lipid-P↑, 4,   MDA↑, 4,   NADH↓, 1,   NADPH/NADP+↓, 1,   NQO1↑, 1,   NRF2↓, 4,   NRF2↑, 7,   p‑NRF2↓, 1,   Prx4↑, 1,   ox-PrxI↑, 1,   RNS↑, 1,   ROS↓, 4,   ROS↑, 66,   ROS⇅, 1,   ROS↝, 1,   i-ROS↑, 1,   mt-ROS↑, 3,   SOD↓, 1,   SOD↑, 1,   SOD1↑, 1,   SOD2↑, 1,   TKT↝, 1,   Trx1↓, 1,   TrxR↓, 4,   TrxR1↓, 1,   xCT/SLC7A11↓, 3,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,   NCOA4↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 1,   CDC25↓, 1,   compI↓, 1,   ETC↓, 2,   mitResp↓, 4,   mtDam↑, 13,   OCR↓, 4,   OCR↑, 2,   OXPHOS↓, 7,   OXPHOS↑, 2,   mt-OXPHOS↓, 3,   PDH↓, 8,   PDH↑, 1,   SDH↓, 1,   SDH↑, 1,   SIRT3↑, 1,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 2,   ACC-α↓, 1,   ACC1↓, 3,   ACLY↓, 2,   ACSL1↓, 1,   ALAT↓, 2,   ALDOA↓, 1,   ALDOB↑, 1,   AminoA↓, 1,   AMPK↑, 15,   p‑AMPK↑, 2,   ATP↓, 42,   ATP↝, 1,   ATP:AMP↓, 1,   CAIX/CA9↓, 1,   citrate↓, 1,   CPT1A↓, 3,   ECAR↓, 9,   ENO1↓, 3,   ENO3↑, 1,   FAO↓, 1,   FAO↑, 1,   FASN↓, 9,   FASN↑, 1,   FBP1↑, 1,   FBPase↑, 1,   G6PD↓, 6,   GAPDH↓, 4,   GLO-I↓, 1,   GLS↓, 3,   glucoNG↓, 1,   glucoNG↑, 1,   glucose↓, 1,   GlucoseCon↓, 46,   GlucoseCon↑, 3,   glut↓, 1,   GlutaM↓, 2,   Glycolysis↓, 105,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 2,   HAGH/GLO2↓, 1,   HK1↓, 4,   HK2?, 1,   HK2↓, 152,   HK2↑, 2,   HK2∅, 1,   HK3↑, 1,   lactateProd↓, 47,   lactateProd↑, 3,   LDHA↓, 44,   LDHA↑, 1,   LDHA∅, 1,   LDL↓, 1,   MCT4↓, 1,   NAD↓, 1,   NADPH↓, 5,   PCK1↑, 1,   PDK1 / PDPK1↓, 14,   PDK3↓, 1,   PDKs↓, 1,   PFK↓, 13,   PFK1↓, 11,   PFK1↑, 1,   PFK2?, 1,   PFK2↓, 2,   PFKFB3↓, 1,   PFKP?, 1,   PFKP↓, 3,   PGK1↓, 1,   PGK2↑, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM2↓, 51,   PKM2↑, 1,   p‑PKM2↓, 1,   PKM2:PKM1↓, 1,   PPP↓, 4,   Pyruv↓, 4,   R5P↝, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 1,   SIRT2↓, 1,   SREBP1/SREBF1?, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 1,   TCA↓, 4,   TPI↓, 1,   Warburg↓, 18,   Warburg↑, 1,   β-oxidation↓, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 3,   APAF1↑, 1,   Apoptosis?, 2,   Apoptosis↑, 53,   mt-Apoptosis↑, 1,   ASK1↑, 1,   BAD↑, 2,   BAX↓, 2,   BAX↑, 14,   Bax:Bcl2↑, 4,   Bcl-2↓, 14,   Bcl-xL↓, 4,   BIM↑, 1,   BNIP3↓, 1,   BNIP3↝, 1,   Casp↑, 6,   Casp∅, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 2,   Casp3↑, 24,   cl‑Casp3↓, 1,   cl‑Casp3↑, 3,   proCasp3↓, 2,   Casp7↑, 3,   Casp8↑, 4,   cl‑Casp8↑, 2,   Casp9↑, 10,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 17,   mt-Cyt‑c↓, 1,   DR5↑, 1,   Endon↑, 1,   Fas↑, 1,   FasL↑, 1,   Ferroptosis↓, 1,   Ferroptosis↑, 3,   GSDME↑, 1,   GSDME-N↑, 1,   IAP1↓, 2,   iNOS↓, 1,   iNOS↑, 1,   Mcl-1↓, 5,   MDM2↓, 2,   MEG3↑, 1,   Necroptosis↑, 1,   necrosis↑, 1,   p38↑, 1,   PUMA↑, 1,   Pyro↑, 2,   RIP3↑, 1,   survivin↓, 7,   TRAIL↑, 2,   TumCD↑, 5,   XIAP↓, 3,   YAP/TEAD↓, 1,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 37,   Akt↑, 1,   p‑Akt↓, 6,   p‑Akt↑, 2,   AKT1↓, 4,   AMPKα↑, 1,   CaMKII ↓, 1,   cMET↓, 1,   p‑cMET↑, 1,   EGFR↓, 12,   ERK↓, 10,   ERK↑, 1,   p‑ERK↓, 1,   HER2/EBBR2↓, 4,   p‑HER2/EBBR2↓, 1,   IGF-1R↓, 1,   IKKα↓, 1,   IKKα↑, 1,   JAK1↓, 1,   JAK2↓, 2,   JNK↓, 2,   JNK↑, 2,   p‑JNK↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 3,   MAPK↑, 1,   mTOR↓, 19,   p‑mTOR↓, 3,   P70S6K↓, 4,   PFKFB2↓, 1,   PHKG1↑, 1,   PI3K↓, 19,   PI3K↑, 1,   PI3K/Akt↓, 1,   PKA↓, 5,   PKCδ↓, 2,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 11,   Raf↓, 1,   RAS↓, 2,   RIP1↓, 1,   RIP1↑, 1,   SHP1↑, 1,   Sp1/3/4↓, 6,   p‑Src↓, 1,   STAT3↓, 12,   p‑STAT3↓, 5,   p‑STAT3↑, 1,   p‑STAT5↓, 1,   STAT6↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 5,   ATF4↝, 1,   cMyc↓, 21,   DNMT1↓, 1,   DNMTs↓, 1,   FOXO1↓, 1,   FOXO3↓, 2,   FOXO3↑, 1,   p‑FOXO3↓, 1,   FOXO4↓, 1,   H3↓, 1,   H3K9↓, 1,   HATs↓, 1,   HDAC↓, 6,   HDAC3↓, 1,   HDAC4↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   miR-122-5p↑, 1,   miR-126↑, 1,   miR-140↑, 1,   miR-145↑, 1,   miR-195↑, 1,   miR-199↑, 1,   miR-200c↑, 1,   miR-206↑, 1,   miR-21↓, 1,   miR-21↑, 1,   miR-221↑, 1,   miR-222↑, 1,   miR-29b↓, 1,   miR-326-5p↑, 1,   miR-34b-5p↑, 1,   Myc↓, 1,   OCT4↓, 4,   other↑, 1,   other↝, 3,   PAX2↓, 1,   SOX2↓, 3,   SOX4↑, 1,   TET3↑, 1,   tumCV↓, 7,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 7,   eIF2α↓, 1,   eIF2α↑, 4,   p‑eIF2α↑, 2,   ER Stress↑, 13,   GRP78/BiP↑, 4,   GRP78/BiP↝, 1,   p‑Hsc70↑, 1,   HSP90↓, 2,   PERK↑, 5,   UPR↑, 6,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 1,   ATG5↝, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3B↑, 1,   LC3B-II↑, 1,   LC3II↑, 2,   p62↓, 3,   p62↑, 1,   RUBCN↓, 1,   TumAuto↑, 16,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   p‑ATM↑, 1,   DNAdam↓, 1,   DNAdam↑, 7,   DNAdam⇅, 1,   DNArepair↓, 1,   hTERT/TERT↓, 6,   NKX3.1↓, 1,   P53↑, 15,   PARP↓, 1,   PARP↑, 1,   cl‑PARP↑, 10,   proPARP↓, 2,   PCNA↓, 4,   SIRT6↑, 1,   TOP1↓, 1,   TOP2↓, 3,   TP53↓, 1,   TP53↑, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   p‑CDK1↓, 1,   CDK2↓, 3,   CDK4↓, 4,   CDK6↓, 2,   CDKN1C/p57↑, 1,   cycA1/CCNA1↓, 2,   CycB/CCNB1↓, 5,   cycD1/CCND1↓, 14,   cycD1/CCND1↑, 1,   Ki-67↓, 7,   mitA↑, 1,   P21↓, 2,   P21↑, 11,   p27/CDKN1B↑, 4,   p‑pRB↓, 1,   RB1↓, 1,   p‑RB1↓, 1,   TumCCA↓, 1,   TumCCA↑, 28,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 2,   ALDH1A1↓, 1,   BMI1↓, 1,   CD24↓, 1,   cFos↓, 1,   CSCs↓, 4,   EIF4E↓, 1,   Gli1↓, 2,   HH↓, 1,   IGF-1↓, 1,   Ki-67↓, 7,   Let-7↑, 2,   mTORC1↓, 3,   Nanog↓, 4,   Nestin↓, 1,   NOTCH↓, 2,   NOTCH1↑, 2,   Shh↓, 3,   Smo↓, 2,   STAT1↓, 1,   TumCG↓, 25,   TumCG↑, 2,   TumCP↓, 41,   TumCP↑, 1,   Wnt↓, 6,  

Migration(tgid=13) ⓘ

AP-1↓, 2,   Ca+2↓, 2,   Ca+2↑, 8,   i-Ca+2↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 11,   EMT↓, 12,   FAK↓, 1,   p‑FAK↓, 1,   Fibronectin↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP-10↓, 2,   MMP2↓, 9,   MMP3↓, 1,   MMP7↓, 2,   MMP9↓, 12,   MMPs↓, 4,   MUC4↓, 2,   N-cadherin↓, 7,   Slug↓, 5,   Snail↓, 5,   talin↓, 1,   TET1↑, 3,   TGF-β↓, 1,   TIMP1↓, 2,   TIMP1↑, 1,   TIMP2↓, 1,   TIMP2↑, 1,   TSC1↑, 1,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 20,   TumCMig↓, 16,   TumMeta↓, 14,   Twist↓, 7,   TXNIP↓, 1,   uPA↓, 1,   Vim↓, 9,   Zeb1↓, 1,   α-SMA↓, 2,   α-SMA↑, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 9,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 12,   CD31/PECAM-1↓, 1,   eNOS↑, 1,   HIF-1↓, 1,   Hif1a↓, 35,   Hif1a↑, 2,   Hypoxia↑, 1,   LOX1↓, 1,   NO↓, 2,   NO↑, 4,   VEGF↓, 12,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

CLDN1↓, 2,   CLDN2↓, 1,   GLUT1↓, 40,   GLUT1↑, 2,   GLUT2↓, 4,   GLUT3↓, 5,   GLUT4↓, 7,   MMP↓, 28,   MMP↑, 2,   MPT↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   CD44↓, 3,   CD8+↑, 1,   COX2/PTGS2↓, 8,   COX2/PTGS2↑, 2,   CXCR4↓, 2,   FOXP3↑, 1,   HCAR1↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   Igs↑, 1,   IL10↓, 3,   IL17↓, 1,   IL1β↓, 4,   IL1β↑, 1,   IL4↓, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 2,   Imm↝, 1,   Inflam↓, 5,   IRAK4↓, 1,   MCT1↓, 2,   NF-kB↓, 23,   p‑NF-kB↓, 1,   NK cell↑, 5,   NLRP3↓, 3,   p65↓, 1,   PD-L1↓, 3,   PGE2↓, 1,   PSA↓, 3,   RAGE↑, 1,   T-Cell↑, 1,   T-Cell↝, 1,   TCF↓, 1,   TLR4↓, 5,   TNF-α↓, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↑, 1,   APP↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3,   ER(estro)↓, 2,   PPARα↓, 1,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 7,   BioAv↑, 8,   BioAv↝, 3,   BioEnh?, 1,   BioEnh↑, 2,   ChemoSen↓, 2,   ChemoSen↑, 33,   ChemoSen⇅, 1,   Dose?, 1,   Dose↓, 1,   Dose↝, 12,   Dose∅, 3,   eff↓, 19,   eff↑, 23,   eff↝, 2,   Half-Life↓, 1,   Half-Life↝, 2,   MDR1↓, 2,   MRP1/ABCC1↓, 2,   P-gp/ABCB1↓, 3,   P-gp/ABCB1∅, 1,   P450↓, 1,   RadioS↑, 10,   RadioS↝, 1,   selectivity↑, 16,   Synergy↑, 28,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALP↓, 1,   AR↓, 3,   AST↓, 1,   BG↓, 1,   EGFR↓, 12,   HER2/EBBR2↓, 4,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 6,   IL6↓, 9,   LDH↓, 13,   LDH↑, 2,   Myc↓, 1,   PD-L1↓, 3,   PSA↓, 3,   RAGE↑, 1,   TP53↓, 1,   TP53↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan?, 1,   AntiCan↑, 4,   AntiTum↑, 3,   cachexia↓, 2,   cardioP↑, 3,   chemoP↓, 1,   chemoPv↑, 2,   hepatoP↑, 1,   memory↑, 1,   neuroP↑, 3,   OS↑, 4,   radioP↑, 1,   RenoP↑, 1,   Strength↑, 1,   toxicity↓, 5,   toxicity↑, 3,   toxicity↝, 2,   TumVol↓, 7,   TumW↓, 5,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 2,   GutMicro↑, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 2,  
Total Targets: 594

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 8,   ARE↑, 1,   Catalase↑, 6,   GPx↑, 4,   GPx1↑, 2,   GPx4↑, 2,   GSH↑, 6,   GSR↑, 2,   GSTs↑, 3,   HDL↑, 2,   HO-1↑, 2,   lipid-P↓, 4,   lipidDe↓, 1,   MDA↓, 3,   NQO1↑, 2,   NRF2↑, 5,   Prx↑, 1,   ROS↓, 15,   ROS↑, 1,   mt-ROS↓, 1,   SOD↑, 7,   SOD1↑, 1,   TAC↑, 1,   Trx↓, 1,   Trx↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mitResp↓, 1,   OCR↓, 1,   OXPHOS↓, 2,   OXPHOS↑, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 1,   p‑ACC↑, 1,   ALAT↓, 1,   ALDOA↑, 1,   p‑AMPK↑, 1,   ATP↑, 3,   ECAR↓, 1,   ECAR↑, 1,   FAO↑, 1,   G6PD↑, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 4,   GlucoseCon↑, 1,   Glycolysis↓, 4,   Glycolysis↑, 5,   Glycolysis↝, 2,   GPI↑, 1,   H2S↑, 1,   HK2↓, 8,   HK2↑, 8,   IDH1↑, 1,   lactateProd↓, 4,   LDHA↓, 2,   LDHA↑, 3,   LDL↓, 1,   lipidLev↓, 1,   NADPH↓, 2,   NADPH↑, 1,   PDKs↓, 1,   PFK↓, 2,   PFK↑, 1,   PFK1↓, 1,   PFK2↓, 1,   PFKL↑, 3,   PFKM↑, 2,   PFKP↓, 1,   PFKP↑, 1,   PKM1↑, 1,   PKM2↓, 4,   PKM2↑, 5,   PPP↓, 1,   SIRT1↑, 1,   SIRT2↑, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 3,   Casp3↓, 1,   Casp9↓, 1,   iNOS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   IGFR↓, 1,   MAPK↓, 1,   mTOR↓, 1,   PFKFB2↓, 1,   PI3K↓, 1,   PTEN↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 1,   other↝, 2,   tumCV↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

IGF-1↓, 2,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   TumCMig↑, 1,   TXNIP↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 2,   E-sel↓, 1,   Hif1a↓, 2,   Hif1a↑, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

GLUT1↑, 2,   GLUT4↑, 3,   MMP↑, 1,   MMP↝, 1,   MUC5AC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   COX2/PTGS2↓, 3,   CXCL1↓, 1,   ICAM-1↓, 1,   IL10↓, 1,   IL17↓, 1,   IL1β↓, 2,   IL2↓, 1,   IL6↓, 1,   IL8↓, 1,   Inflam↓, 12,   NF-kB↓, 5,   RAGE↓, 1,   SOCS-3↓, 1,   TNF-α↓, 4,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 2,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   FGF21↑, 1,   PPARα↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 6,   BioAv↑, 2,   BioAv↝, 1,   BioEnh↑, 1,   Dose?, 1,   Dose↝, 3,   P450↓, 1,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AST↓, 2,   IL6↓, 1,   RAGE↓, 1,   TC↓, 1,   TG/TAG↓, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 4,   AntiArt↑, 2,   AntiDiabetic↑, 1,   cardioP↑, 4,   chemoP↑, 1,   cognitive↑, 3,   hepatoP↑, 7,   Learn↑, 1,   memory↑, 2,   neuroP↓, 1,   neuroP↑, 7,   OS↑, 1,   RenoP↑, 2,   Stroke↓, 1,   toxicity↓, 5,   toxicity↝, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 1,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 164

Scientific Paper Hit Count for: HK2, Hexokinase 2
14 3-bromopyruvate
9 Sulforaphane (mainly Broccoli)
8 Quercetin
8 Propolis -bee glue
7 2-DeoxyGlucose
7 Baicalein
7 EGCG (Epigallocatechin Gallate)
7 Resveratrol
6 Metformin
6 Chrysin
5 Shikonin
4 Curcumin
4 Graviola
4 Methyl Jasmonate
3 Berberine
3 Capsaicin
3 Citric Acid
3 Fenbendazole
3 Matrine
3 Ursolic acid
2 Apigenin (mainly Parsley)
2 Baicalin
2 Cinnamon
2 Chemotherapy
2 Emodin
2 Kaempferol
2 Licochalcone A
2 Licorice
2 Magnetic Fields
2 Pachymic acid
2 Piperlongumine
2 Silymarin (Milk Thistle) silibinin
2 Vitamin C (Ascorbic Acid)
2 Vitamin D3
1 Sorafenib (brand name Nexavar)
1 Radiotherapy/Radiation
1 cetuximab
1 Alpha-Lipoic-Acid
1 doxorubicin
1 Artemisinin
1 Ashwagandha(Withaferin A)
1 5-fluorouracil
1 Betulinic acid
1 Benzyl isothiocyanate
1 Caffeic acid
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Chlorogenic acid
1 chaetocin
1 Deguelin
1 Diclofenac
1 diet FMD Fasting Mimicking Diet
1 diet Methionine-Restricted Diet
1 Taurine
1 Piperine
1 flavonoids
1 Ginkgolide B
1 Hydrogen Gas
1 Honokiol
1 Isorhamnetin
1 Isothiocyanates
1 Ivermectin
1 Laetrile B17 Amygdalin
1 lambertianic acid
1 Luteolin
1 Magnolol
1 Methylglyoxal
1 Melatonin
1 Moringa oleifera
1 Oroxylin-A
1 Proanthocyanidins
1 Phenylbutyrate
1 Rosmarinic acid
1 Terpenoids
1 Thymoquinone
1 triptolide
1 Vitamin K2
1 Wogonin
1 Worenine
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:773  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page